BREAKING NEWS
Covid-19 Drugs
Covid-19 Drugs
Source: COVID-19 Scams  Nov 22, 2020  11 months ago
COVID-19 Scams: More emerging news coming out from the land of COVID-19 Scams-America. After the hydrochloroquinone, convalescent plasma and remdesivir sagas, we have the Eli lily monoclonal drug and now the Regeneron’s antibody cocktail drug being granted emergency authorization or EUA status to treat COVID-19. It was already expected news as many were sure that Trump has to oblige his...
Source: COVID-19 Breakthroughs  Nov 20, 2020  11 months ago
COVID-19 Breakthroughs: A new breakthrough study led by researchers from St. Jude Children's Research Hospital-Memphis along with scientist from University of Tennessee Health Science Center have discovered that inflammation in COVID-19 patients were not just caused by cytokine storms per se or even just by bradykinin storms but rather were triggered by what is known as PANoptosis.   PA...
Source: COVID-19 Intranasals  Nov 20, 2020  11 months ago
COVID-19 Intranasals: Scientists from the University of Birmingham have developed a nasal spray that can provide effective protection against the SARS-CoV-2 coronavirus by using materials already cleared for use in humans.   Airborne pathogens pose high risks in terms of both contraction and transmission within the respiratory pathways, in particular the nasal region. Although knowledge of ...
Source: COVID-19 Scams  Nov 20, 2020  11 months ago
COVID-19 Scams: Finally the world is seeing more day by day the scams perpetrated by American entities including the NIH, CDC, FDA, the Trump Administration and individuals like Dr Anthony Fauci, billionaires like Tom Cahill and politicians like Nick Ayers and Mike Spence.   One of the biggest scams that is coming to light is remdesivir, an overpriced drug that had no efficacy against COVID...
Source: COVID-19 Drugs:  Nov 16, 2020  11 months ago
COVID-19 Drugs: A new study by Taiwanese researchers from Chang Gung University, Kaohsiung Medical University, Chang Gung Memorial Hospital, Ming Chi University of Technology and Puxin Fengze Chinese Medicine Clinic have found that strategies using drugs and therapeutics to target neutrophils help to reduce and treat respiratory distress syndrome (ARDS)  in severe COVID-19 patients.   ...
Source: COVID-19 Prophylaxis  Nov 09, 2020  11 months ago
COVID-19 Prophylaxis: A recent study by All India Institutes of Medical Sciences (AIIMS)-Bhubaneswar in the Indian state of Odisha found that two doses of the drug ivermectin served as a prophylaxis that resulted in a 73% reduction in COVID-19 infection.   In the study that was also propelled by Thailand Medical News research initiatives, ivermectin prophylaxis was taken by 77 controls and ...
Source: COVID-19 Mortality   Nov 05, 2020  12 months ago
COVID-19 Mortality risk was found to be reduced by 22% to 25% in individuals taking statins according to a Spanish study. The retrospective observational study involved patients taking statins who were 11 years older and had significantly more comorbidities than patients who were not taking statins. A genetic matching (GM) procedure was performed prior to analysis of the mortality risk. ...
Source:  Nov 04, 2020  12 months ago
COVID-19 Drugs: Researchers from the University of South Australia, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS)-Italy  and  University of Campania-Italy in a new international study propose that beta-blockers could potentially be used to treat COVID-19. COVID-19 disease which has now rapidly spread around the globe causing severe pneumonia is often linked to Acute Respir...
Source: COVID-19 Drugs  Nov 02, 2020  12 months ago
COVID-19 Drugs: With the current COVID-19 pandemic fast escalating and no effective drugs to date, researchers around the world are desperately trying to find suitable drug candidates to further explore their efficacy against the SARS-CoV-2 coronavirus. In two separate studies, two possible drug candidates that demonstrated to inhibit the SARS-CoV-2 virus were identified, one being 5-Amino Levulin...
Source: COVID-19-Antibodies  Oct 30, 2020  12 months ago
COVID-19-Antibodies:  The independent data monitoring committee (IDMC) has recommended that Regeneron ‘s clinical trial of its antibody treatment called REGN-COV2 for severe COVID-19 patients needing oxygen or who are on ventilators be suspended with immediate effect. The decision was made in the last 24 hours and Regeneron was legally obliged to comply immediately.   On early Fr...
Source: COVID-19 Drugs  Oct 26, 2020  12 months ago
COVID-19 Drugs: Researchers from Yale University School of Medicine in a new study exploring the inhibitory effects of the drug merofloxacin on frameshifting during SARS-CoV-2 replication have reported positive results in vitro studies. The study findings are an important proof-of-concept that supports the potential for targeting −1 PRF (programmed −1 ribosomal frameshifting) as a...
Source: Aspirin-COVID-19  Oct 24, 2020  12 months ago
Aspirin-COVID-19: A new study led by researchers from University of Maryland School of Medicine (UMSOM) shows that hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin.   Importantly, aspirin takers were less likely to be placed...
Source: COVID-19 -Dexamethasone  Oct 24, 2020  12 months ago
COVID-19 -Dexamethasone: A new study led by researchers from University of Virginia-U.S. along with scientist from Polish Academy of Sciences-Poland, Poznan University of Technology-Poland, Medical University of Bialystok-Poland and University of South Carolina-U.S. has discovered a about how the human body transports dexamethasone, a drug that can increase the survival chances of patients wi...
Source: America Latest  Oct 23, 2020  12 months ago
America Latest: America is facing a major health crisis with the Trump Administration in power and the degree of incompetency, greed and corruption in play. Already America has a total of more than 8.4 million confirmed COVID-19 cases with realistic figures expected to be much higher due to under-reporting in Republican controlled states and lack of testing among asymptomatic cases and as of today...
Source: Drugs-COVID-19  Oct 22, 2020  1 year ago
Drugs-COVID-19: Fortunately another COVID-19 drug scam is being prevented after the remdesivir saga thanks to honest and credible researchers that cannot be manipulated by money. The US FDA under the Trump administration and Trump’s family and cronies has done even damage with hydrochloroquine and remdesivir issues with many American lives lost and hopefully after Trump loses this elections,...
Source: COVID-19 Drugs  Oct 20, 2020  1 year ago
COVID-19 Drugs: Ensifentrine a drug originally developed by UK based pharmaceutical cum biotech company Verona Pharma to treat chronic obstructive pulmonary disease or COPD could be a new treatment option for hospitalized COVID-19 patients. According to research this dual bronchodilator and anti-inflammatory drug be safe and effective in COVID-19 patients experiencing the debilitating effects of s...
Source: Remdesivir  Oct 16, 2020  1 year ago
Remdesivir:  Interim results from the Solidarity Therapeutics Trial, coordinated by the World Health Organization, indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients.   The study results of the trial are under review for publi...
Source: COVID-19 Intranasal Drugs  Oct 15, 2020  1 year ago
COVID-19 Intranasal Drugs: North Carolina based clinical-stage biotechnology company Novan, Inc. that specializes in various nitric oxide based therapeutics has announced that its vitro studies involving its NITRICIL™ platform technology that uses berdazimer sodium has demonstrated antiviral effects against the SARS-CoV-2 coronavirus tha causes the COVID-19 disease.   Berdaz...
Source: COVID-19 Therapeutics  Oct 13, 2020  1 year ago
COVID-19 Therapeutics: According to new research carried out at the University of St Andrews-Scotland, a new inhalation treatment protocol and drug involving synthetic interferons to  prevent the spread of COVID-19 is potentially far more effective than currently existing versions of interferons or inhalation protocols.   The Scottish biotech company, ILC Therapeutics based in Newhouse...
Source: COVID-19 Drugs  Oct 12, 2020  1 year ago
COVID-19 Drugs:  A new vivo study involving animal models by researchers from Hong Kong University show that the cheap stomach ulcer drug ranitidine bismuth citrate (Tritec) is able to inhibit the SARS-CoV-2 coronavirus.   The study team on Monday announced that the anti-microbial drug used to treat stomach ulcers and bacterial infections has shown promise in combatting the coronavirus...
Source: COVID-19 Help  Oct 11, 2020  1 year ago
COVID-19 Help: While tens of thousands are getting infected daily and thousands are dying each day, millions elsewhere are worried and are trying to find ways to help themselves and their loved ones and the only thing that stupid health authorities and incompetent corrupted governments around the world are doing are giving false hopes by an anticipated COVID-19 vaccine that many think will solve t...
Source: COVID-19 Scams  Oct 09, 2020  1 year ago
COVID-19 Scams?  As anticipated, Eli Lily and Regeneron have applied for emergency approval for their laboratory -produced antibodies against COVID-19 and Donald Trump aka ‘Loony Dump Trump’ has signaled his strong presidential backing based on the fact he was treated with them. (There no proof if he was really infected and the whole thing could have been elaborately staged or is ...
Source: COVID-19 Treatments   Oct 06, 2020  1 year ago
COVID-19 Treatments: Australian researchers from The University of Newcastle, Hunter Medical Research Institute-New South Wales, University of Technology Sydney and Chinese scientists from Jilin University-Changchun have in a new study confirmed that the SARS-CoV-2 spike glycoprotein subunit 1 can induce a pro-inflammatory signaling pathway (leading to cytokines deployment and epithelial...
Source: COVID-19 Breakthrough  Oct 06, 2020  1 year ago
COVID-19 Breakthrough: Canadian researchers have made a major breakthrough during a study on UPR or unfolded protein response during coronaviruses viral replication leading them to a discovery of thiopurines to stop the viral replication of human coronaviruses including SARS-CoV-2. This breakthrough with further research could lead to a new and effective broad-spectrum therapeutic antiviral that c...
Source: COVID-19 Drugs  Oct 03, 2020  1 year ago
COVID-19 Drugs: An urgent immediate safety review of the drug Remdesivir has been called by the European Medicines Agency after numerous COVID-19 patients taking the drug have developed serious kidney problems.   The EU regulator issued a statement a few hours ago saying that it seemed that remdesivir was causing the "acute kidney injury," and that the issue "warrants further...
Source: Drugs-COVID-19  Oct 01, 2020  1 year ago
Drugs-COVID-19: Anti-tumour necrosis factor (anti-TNF) drugs or TNF inhibitors are now being explored by numerous researchers to treat COVID-19 after recent studies of patients with COVID-19 have shown that patients already taking anti-TNF drugs for inflammatory bowel disease and inflammatory arthritis are less likely to be admitted to hospital. The same was not observed for patients taking other ...
Source: COVID-19 Intranasal Drugs  Sep 30, 2020  1 year ago
COVID-19 Intranasal Drugs: Researchers from the National Infection Service-UK, Ena Respiratory, Melbourne-Australia, The University of Melbourne-Australia, University of Newcastle-Australia and Oxford University-UK are exploring the usage of TLR2/6 Agonist INNA-051 as an intranasal prophylaxis against COVID-19.   To date their vivo studies involving animal models showed that the TLR2 agonis...
Source: COVID-19 Research  Sep 30, 2020  1 year ago
COVID-19 Research: A study led by researchers from the University of Cincinnati along with scientists from University of Duisburg-Germany, the German Primate Center  and Saarland University-Germany have discovered that sphingosine, a naturally occurring lipid in the human body could be used as a potential treatment for COVID-19 as prevents binding of SARS-CoV-2 spike to its cellular receptor ...
Source: COVID-19-Povidone-Iodine  Sep 27, 2020  1 year ago
COVID-19- Povidone-Iodine: A study led by researchers from the University of Connecticut School of Medicine-Farmington along with experts from The Institute for Antiviral Research at Utah State University, Veloce BioPharma-Florida, ProHealth-Farmington and Ocean Ophthalmology-Florida has demonstrated that an antiseptic nasal spray containing povidone-iodine may help curb transmission of the SARS-C...
Source: Metformin-COVID-19  Sep 26, 2020  1 year ago
Metformin-COVID-19: A few past research studies  the last few months has shown the possibility of using metformin, the common cheap and easily available diabetes drug being used for COVID-19 treatments as it was found to reduce severity and mortality rates in COVID-19 patients. In one study, the researchers found that among more than 600 patients with diabetes and COVID-19, use of metformin ...
Source: COVID-19 Treatments  Sep 24, 2020  1 year ago
COVID-19 Treatments: Two new studies by researchers from the University of California-San Diego show that statin usage is linked to a lower risk of developing COVID-19 severity and that removing cholesterol from cell membranes prevents the virus from getting into these cells.   Furthermore there is some biologic plausibility for a protective role of statins in COVID-19 through known anti-in...
Source: COVID-19 Treatments  Sep 22, 2020  1 year ago
COVID-19 Treatments: Medical researchers and physicians are now trying interrupt the SARS-CoV-2 coronavirus before it gets into the lungs and the rest of the body and starts ravaging the body, targeting not only the lungs, heart and blood vessels but even the cerebrospinal fluids, the brain, the kidneys, the gastroenterological tract , the male testis to even the immune system itself.   The...
Source: COVID-19 Scams-Russia  Sep 22, 2020  1 year ago
COVID-19 Scams: It was announced that Russia has approved R-Pharm's Coronavir treatment for outpatients with mild to moderate COVID-19 infections and the antiviral drug could be rolled out to pharmacies throughout the country as soon as next week, the company said on Friday.   The drug’s approval as a prescription drug follows the green light for another Russian COVID-19 drug, Avi...
Source: COVID-19 Scams  Sep 21, 2020  1 year ago
COVID-19 Scams: Of all the stupidity and craziness which not many people are questioning (the intelligence levels in America has sunk to its lowest!) is the new American standard for drug approvals set by the US FDA under the Trump administration in which as long you can demonstrate somehow by whatever means that a drug is able to shorten hospitalization stays, Voila! You get approved and you can ...
Source: Drugs-COVID-19  Sep 21, 2020  1 year ago
Drugs-COVID-19: Spanish researchers from the Department of Cell Biology at the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have identified 4-Phenylbutiric acid or 4-PBA as a possible drug candidate to treat the various inflammatory and immune issues resulting from the SARS-CoV-2 coronavirus infection that causes COVID-19 disease.   The s...
Source: Coronavirus Supplements  Sep 18, 2020  1 year ago
Coronavirus Supplements: Researchers from the University of Nebraska Medical Center and Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring have demonstrated in vitro studies that bromelain extracted from pineapples is able to inhibit the SARS-CoV-2 coronavirus in Vero E6 cells via a  multitude of ways.   The study findings are published on a preprint server and are...
Source: Coronavirus Antivirals  Sep 17, 2020  1 year ago
Coronavirus Antivirals: Researchers from University of Chinese Academy of Sciences, Shanghai-China have identified the antibiotic Ceftazidime as possible antiviral candidate to inhibit SARS-CoV-2 coronavirus and treat the COVID-19 disease. The research findings were published on a preprint server and have yet to be peer reviewed. https://www.biorxiv.org/content/10.1101/2020.09.14.295956v1   ...
Source: COVID-19 Immunotherapy  Sep 17, 2020  1 year ago
COVID-19 Immunotherapy: Researchers from Corvus Pharmaceuticals Inc-California, Temple University-Philadelphia and Icahn School of Medicine at Mount Sinai-New York in a phase 1 clinical trial have demonstrated that using a Inhibitor Of CD73 Enzymatic Activity called CPI-006, the researchers were able to induce the effective B Cell and Humoral response to SARS-CoV-2 infection in COVID-19 patients e...
Source: COVID-19 Meds  Sep 17, 2020  1 year ago
COVID-19 Meds: A new vitro study led by Austrian researchers from the University of Vienna has demonstrated that the nasal antihistamine Azelastine was able to inhibit SARS-CoV-2 infections in assays using reconstituted human nasal tissue and Vero E6 monkey kidney epithelial cells. The study team says that Azalastine is a prospective drug candidate that could be used to reduce viral transmission i...
Source: COVID-19 Drugs  Sep 17, 2020  1 year ago
COVID-19 Drugs: Azithromycin, a commonly-prescribed antibiotic that also is being investigated as a potential treatment for COVID-19 according to a new study by researchers from the University of Illinois Chicago, by itself is not associated with an increase in cardiac events; however, if taken with certain other drugs that affect the electrical functioning of the heart, then cardiac events increa...
Source: COVID-19 Drugs  Sep 14, 2020  1 year ago
COVID-19 Drugs: Researchers from the University of Pittsburgh School of Medicine claim to have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 coronavirus.   The research findings were published in the journal: Cell https://www.cell.com/cell/pdf/S0092-8674(20)31148-X.pdf?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%...
Source: COVID-19 Breakthrough  Sep 13, 2020  1 year ago
COVID-19 Breakthrough: Clinical-stage biopharmaceutical company Senhwa Biosciences that is based in Taiwan with offices in San Diego has announced that its investigational drug, Silmitasertib has demonstrated remarkable effectiveness after the first patient with severe COVID-19 demonstrated remarkable recovery after using the drug. Senhwa Biosciences is a company focused on next generation DNA Da...
Source: COVID-19 Treatments  Sep 12, 2020  1 year ago
COVID-19 Treatments: Researchers from Mississippi have in a new study found that utilizing both the antihistamines Cetirizine and Famotidine appears to reduce pulmonary symptoms and may have other benefits in patients with COVID-19. The study findings were published in the journal:  Pulmonary Pharmacology & Therapeutics https://www.sciencedirect.com/science/article/pii/S1094553920301462?...
Source: COVID-19 Convalescent Plasma  Sep 10, 2020  1 year ago
COVID-19 Convalescent Plasma: An open-label, parallel-arm, phase II, multicentre, randomized controlled trial (PLACID) in India has shown that the use of convalescent plasma as a therapeutic for moderate COVID-19 patients showed no positive effects and did not improve the outcome of the patients.   The study findings are published on a preprint server and are currently being peer reviewed. ...
Source: Drugs And COVID-19  Sep 09, 2020  1 year ago
Drugs And COVID-19: Danish researchers led by Dr Anton Pottegård of the University of Southern Denmark along with other scientists from Aarhus University Hospital and the Danish Medicines Agency have in a new study found that the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and diclofenac, is not associated with any adverse effects in people who have tested p...
Source: Drugs-COVID-19  Sep 08, 2020  1 year ago
Drugs-COVID-19: Researchers from Memorial Sloan Kettering Cancer Center-New York in a new study suggest that using drugs such as PI3K/mTOR And Topoisomerase inhibitors reduces ACE2 expression and reduces risk and an individual’s susceptibility to the SARS-CoV-2 coronavirus that causes the COVID-19 disease.   As ACE2 are the main and first receptors that the SARS-CoV-2 coronavirus uses...
Source: Narsoplimab And COVID-19  Sep 06, 2020  1 year ago
Narsoplimab And COVID-19: Researchers are now saying that treatments for COVID-19 may be focusing on at the wrong elements of the disease based on emerging data from Bergamo, Italy, the epicenter of the pandemic in Europe.   Italian researchers realized, as they combed through the data, that COVID-19 is an endothelia injury rather than a pulmonary event and that stopping the complement casc...
Source: COVID-19 Bradykinin Storms  Sep 03, 2020  1 year ago
By detailed analysis of data on more than 40,000 genes , 17,000 genetic  and 2.5 billion genetic combinations samples linked to COVID-19, researchers from Oak Ridge National Lab in Tennessee have managed by using the world’s second fastest computer called the Summit supercomputer have come up with a hypothesis as to how the SARS-CoV-2 coronavirus affects the human host dubbed the &...
Source: COVID-19 Drugs  Aug 28, 2020  1 year ago
COVID-19 Drugs: Canadian researchers from the University of Alberta are preparing to launch clinical trials of a drug called GC376 ( A prodrug of the parent drug called GC373) used to cure a deadly disease caused by a coronavirus in cats and they expect will also be effective as a treatment for humans against COVID-19 after successful vitro studies.   The study findings or the vitro trials ...
Source: Nitric Oxide For COVID-19  Aug 27, 2020  1 year ago
Nitric Oxide For COVID-19: According to researchers from Massachusetts General Hospital (MGH), inhaled nitric oxide (NO) can be a valuable adjunct respiratory therapy for pregnant women with severe and critical COVID-19. It was found that the delivery of the therapeutic gas to six COVID-19 pregnant patients admitted to MGH, resulted in a rapid and sustained improvement in cardiopulmonary function...
Source: COVID-19 Diagnostics  Aug 27, 2020  1 year ago
COVID-19 Diagnostics: Researchers from Lawson Health Research Institute and Western University in a news study have identified six molecules that can be used as biomarkers to predict how severely ill a patient will become.   The research findings were published in the Journal: Critical Care Explorations, the official journal of the Society Of Critical Care Medicine https://journals.lww.com/...
Source: Medical News  Aug 26, 2020  1 year ago
Medical News: Estradiol, the estrogen steroid hormone might confer a certain degree of protection to females claims a new study by European and American reseachers. According to a new study by researcher from Universitätsmedizin Berlin-Germany,  Sapienza University of Rome-Italy,  Sant’Andrea University Hospital-Italy and University of Virginia-USA, it appears that wome...
Source: Coronavirus Treatments  Aug 26, 2020  1 year ago
Coronavirus Treatments: Japanese researchers from Japan’s National Institute of Infectious Diseases are banking their hopes on an inhaled steroid called ciclesonide as the drug has both antiviral and also anti-inflammatory properties against the SARS-CoV-2 coronavirus. In a recent study, the study team reports the in vitro suppression of both the MERS coronavirus and also the SARS-Cov-2 cor...
Source: COVID-19 Treatments  Aug 26, 2020  1 year ago
COVID-19 Treatments: A second clinical observation study, this time conducted by researchers from Harford hospital-Connecticut have demonstrated that administering famotidine to hospitalized COVID-19 patients was associated with a reduction in death and a composite endpoint of either death or intubation. The study involved 878 hospitalized COVID-19 patients of which 83 (9.5%) r...
Source: COVID-19 News  Aug 25, 2020  1 year ago
COVID-19 News: According to new research from the University of East Anglia-UK, medication for high blood pressure could improve COVID-19 survival rates and reduce the severity of infection.   The study team meta-analyzed data from a variety of sources involving more than 28,000 patients taking antihypertensives, a class of drugs that are used to treat hypertension also known as high blood ...

MOST READ

Feb 05, 2020  2 years ago
Source : Thailand Medical news

Interesting Reads

Source: COVID-19 Convalescent Plasma and Hyperimmune Plasma Or H-Ig Therapies
Jun 15, 2020  1 year ago
Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020  1 year ago
Source: COVID-19 Long-Term Health Implications
Jun 13, 2020  1 year ago
Source: COVID-19, Influenza and Next Wave
Jun 10, 2020  1 year ago
Source: Myocardial Injury
Jun 09, 2020  1 year ago
Source: COVID-19 News
May 21, 2020  1 year ago
Source: Covid-19 Treatments And Drugs News
Mar 20, 2020  2 years ago
Source: SARS-Cov-2 Coronavirus Research
Mar 08, 2020  2 years ago
Source : Thailand Medical News
Feb 11, 2020  2 years ago